Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Pharmaceutical expenditures in ambulatory care rose rapidly in Europe in the 1990s and early 2000s. This was typically faster than other components of healthcare spending, leading to reforms to moderate future growth. A number of these centered on generic medicines with measures to lower reimbursed...

Full description

Bibliographic Details
Main Authors: F. Cankat Tulunay, Kamila Wendykowska, Inês Teixeira, Catherine Sermet, Ulrich Schwabe, Roberta Joppi, Ott Laius, Marija Kalaba, Kristina Garuolienè, Thomas Burkhardt, Morten Andersen, Iain Bishop, Bjorn Wettermark, William Shrank, Brian Godman, Corinne Zara, Lars L Gustafsson
Format: Article
Language:English
Published: MDPI AG 2010-08-01
Series:Pharmaceuticals
Subjects:
generic drugs
generic substitution
cost containment
pricing
Online Access:http://www.mdpi.com/1424-8247/3/8/2470/

Internet

http://www.mdpi.com/1424-8247/3/8/2470/

Similar Items